reports
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Res...
Lifecore Biomedical Reports First Quarter of Fiscal 2025 Financial Results and Provides Corporate Update -- Recorded Revenues of $24.7 Million for Q1 Fiscal 2025 -- -- Signed Multiple New Business Agreements with New and Existing Customers -- -- More than Doubled Capacity with Installation of 5-Head Isolator Filler; Increased Revenue Generating Potential to Up to $300 Million Annually -- -- Successfully Closed Financing Raising Approx. $24.3 Million, Providing Financial Runway for Current Liquidity Needs and Future Growth -- Conference Call Today at 8:30 a.m. ET CHASKA, Minn., Oct. 04...
Lifecore Biomedical Raises $24.3 Million in Private Placement of Commo...
Lifecore Biomedical Raises $24.3 Million in Private Placement of Common Stock PIPE with New and Existing Investors Supports Working Capital and Operations CHASKA, Minn., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced the closing of a $24.3 million private placement (“PIPE”) of 5,928,775 shares of its common stock at a price of $4.10 per share. The investing group includes new and existing shareholders, and the company expects to use the proceeds for working capital...
Lifecore Biomedical to Report Financial Results for First Quarter of F...
Lifecore Biomedical to Report Financial Results for First Quarter of Fiscal 2025 Prior to Market Open on October 4, 2024 CHASKA, Minn., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the first quarter of fiscal year 2025 on Friday, October 4, 2024, prior to market open and will host a webcast at 8:30 a.m. Eastern Time. Members of Lifecore’s senior management team will discuss financial results for the first quarter...
Lifecore Biomedical Selected by Lindy Biosciences to Support Process D...
Lifecore Biomedical Selected by Lindy Biosciences to Support Process Development and Commercial Scale-Up for Innovative Microglassification Formulation Technology Multi-Million Dollar Development Agreement Establishes Lifecore as Lindy Biosciences’ Preferred CDMO Offers Lifecore Key Access Point into Manufacture and Fill/Finish of Next-Generation Biotherapeutic Formulations with Potential to Deliver Significant Benefits to Patients Worldwide CHASKA, Minn., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and m...
Lifecore Biomedical to Participate at Upcoming Industry Conferences an...
Lifecore Biomedical to Participate at Upcoming Industry Conferences and Events CHASKA, Minn., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate at four upcoming industry events. Details of the company’s activities at these events are as follows: Medical Aesthetic Injectable Summit 2024Conference Date/Location: October 4-5, 2024, in Marbella, SpainDetails: Darren Hieber, Lifecore’s senior vice president of corporate develo...
Daxor Corporation to Exhibit at the Heart Failure Society of America A...
Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024 Oak Ridge, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces its participation in the Annual Scientific Meeting of the Heart Failure Society of America (HFSA), taking place September 27-30 at the Georgia World Congress Center and Signia by Hilton Atlanta. The event will gather the world’s top heart failure experts. Key meeting highlights: Exclusive showcase of BVA at the HFSA 'Devices in Heart Failure: ...
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolato...
Lifecore Biomedical Announces High-Speed, Multi-Purpose 5-Head Isolator Filler is GMP-Ready and Operational Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and Cartridges Offers State-of-the-Art Speed and Aseptic Isolation Required for Fill/Finish of Latest Sterile Injectable Pharmaceutical and Biopharmaceutical Products Current Capacity More than Doubles with New Filler CHASKA, Minn., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore”), a fully integrated contract development and manufactur...
Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Confe...
Lifecore Biomedical to Participate in Craig-Hallum Bioprocessing Conference CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Paul Josephs, the Company’s president and chief executive officer, and Ryan Lake, the Company’s chief financial officer, will be the featured speakers in a fireside chat at the upcoming Craig-Hallum Bioprocessing Conference. The conference will take place virtually on September 19, 2024. Details a...
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Vo...
Newly Published Review Highlights the Pivotal Role of Daxor’s Blood Volume Analysis Technology in Advancing Cardiorenal Syndrome Management Review Published in the Prestigious Journal Cardiorenal Medicine Oak Ridge, TN, Sept. 12, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces a review published in the journal Cardiorenal Medicine that delves into the intricate landscape of cardiorenal syndrome (CRS) and highlights the pivotal role of Blood Volume Analysis (BVA) in improving patient care and outcomes. Key find...
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirement...
Lifecore Biomedical Regains Compliance with Nasdaq Listing Requirements CHASKA, Minn., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it has received written notice from the Nasdaq Listing Qualifications Department stating that the Company has regained compliance with the filing requirement in Nasdaq Listing Rule 5250(c), which requires listed companies to timely file all required periodic financial reports with the Securities and E...
Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice Preside...
Lifecore Biomedical Appoints Brikkelle Thompson as Senior Vice President of Human Resources Ms. Thompson Brings Nearly 25 Years of HR Leadership Driving Top Performing Cultures and Building Exceptional Teams CHASKA, Minn., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced the appointment of Brikkelle Thompson as senior vice president of human resources. Ms. Thompson brings nearly 25 years of visionary human resources leadership, global exp...
Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing R...
Lifecore Biomedical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CHASKA, Minn., Sept. 06, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Lifecore has granted a restricted stock unit (“RSU”) award with respect to 262,500 shares of its common stock and a performance stock unit (“PSU”) award for up to 750,000 shares of its common stock to Ryan D. Lake, Lifecore’s newly hired chief financial officer. The RSU award and PSU award...
Lifecore Biomedical to Participate in 17th Annual Barrington Research ...
Lifecore Biomedical to Participate in 17th Annual Barrington Research Virtual Fall Investment Conference CHASKA, Minn., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the Company will participate in the upcoming 17th Annual Barrington Research Virtual Fall Investment Conference. Lifecore management will participate in 1-on-1 investor meetings during the event, which is scheduled to take place virtually on Thursday, September 12, 2024...
Daxor Corporation Receives $300K Matching Fund Award From Launch Tenne...
Daxor Corporation Receives $300K Matching Fund Award From Launch Tennessee The SBIR Matching Fund Award Will Drive Our Innovation, Commercialization Efforts, and Job Creation Oak Ridge, TN, Sept. 05, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces Launch Tennessee (LaunchTN) awarded Daxor Corporation a $300K SBIR matching fund to advance its next-generation point-of-care blood volume analyzer, building on Daxor’s Phase II award from the Defense Health Agency. “This award is a welcome addition to Daxor’s long-standing and...
Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Vol...
Leading Central Florida Hospital Implements Daxor’s BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care 1,000 Bed Comprehensive Medical Center Launches ezBVA Lab Program Oak Ridge, TN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the expansion of its blood volume analysis (BVA) capabilities through its ezBVA Lab service. Daxor will partner with the hospital to provide lab processing of its patient tests, providing a rapid 24-hour testing service that is highly efficient for the hospital to impleme...
Daxor Corporation CEO and President Michael Feldschuh Delivers Corpora...
Daxor Corporation CEO and President Michael Feldschuh Delivers Corporate Update in Shareholder Letter Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: DXR), the global leader in blood volume measurement technology, today provides a mid-year corporate and financial update in a Letter to Shareholders from CEO and President Michael Feldschuh. Dear Valued Shareholders, I am pleased to present our mid-year update for our unaudited first half results of 2024, highlighting Daxor Corporation's remarkable progress and financial performance. Our commitment to innovation in blood volume...
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global...
Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will present at the H.C. Wainwright 26th Annual Global Investment Conference being held on September 9-11, 2024 in New York City at the Lotte New York Palace Hotel. The presentation will be available on-demand beginning September 9, 2024 at 7:00 AM ET. Investors who wish to listen to the Company’s presentation can do ...
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
TCBI TEXAS CAPITAL BANCSHARES INC.
PBF PBF ENERGY INC. CLASS A
OOMA OOMA
MPAA MOTORCAR PARTS OF AMERICA INC.
LANC LANCASTER COLONY CORPORATION
IMMR IMMERSION CORP.
HNRG HALLADOR ENERGY CO.
GLP GLOBAL PARTNERS LP
FLDM FLUIDIGM
FFIN FIRST FINANCIAL BANKSHARES INC
CTRN CITI TRENDS INC.
CRK COMSTOCK RESOURCES INC.
BEN FRANKLIN RESOURCES INC.
APEI AMERICAN PUBLIC EDUCATION
ATEC ALPHATEC HOLDINGS INC.
DKL DELEK LOGISTICS PARTNERS
MYRG MYR GROUP INC.
EPD ENTERPRISE PRODUCTS PARTNERS L.P.
GBDC GOLUB CAPITAL BDC INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
APPN APPIAN
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ISDR ISSUER DIRECT CORP.
AXR AMREP
ELAN ELANCO ANIMAL HEALTH INC.
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
GRWG GROWGENERATION
ONEW ONEWATER MARINE
BILL BILL.COM HOLDINGS
HPK HIGHPEAK ENERGY INC (A)
ABCL ABCELLERA BIOLOGICS
LESL LESLIES
BFLY BUTTERFLY NETWORK INC (A)
INBX INHIBRX
IMMX INC.
NN IMMIX BIOPHARMA INC
NXGL NEXTNAV INC
BIGZ NEXGEL INC
PFHC BLACKROCK INNOVATION AND GROWTH TST
CALC PROFRAC HLDG CORP
ATMU CALCIMEDICA INC.
ET ATMUS FILTRATION TECHNOLOGIES INC
MIO ENERGY TRANSFER LP
PEO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
SUNS PETROLEUM & RESOURCES CORPORATION
XPER SUNRISE REALTY TRUST
OBDE XPERI INC
LOCO OWL ROCK CAPITAL CORP III
LOVE OIL INC.
Daxor Corporation Announces Launch of BVA Program at Mid-South Largest...
Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network Community Hospital Purchases BVA Analyzer With Focus on Improving Outpatient Heart Failure Care Oak Ridge, TN, Aug. 29, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: DXR), the global leader in blood volume measurement technology, announces the expansion of its blood volume analysis (BVA) technology through the acquisition of the BVA analyzer. This advancement not only enhances revenue streams, but also sets the stage for projected accelerated sales growth for the rest of the year. A rural 339-bed community ho...
Lifecore Biomedical Announces Chief Financial Officer Transition
Lifecore Biomedical Announces Chief Financial Officer Transition Experienced CDMO Industry Financial Executive Ryan Lake Appointed CFO CHASKA, Minn., Aug. 29, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: ) (“Lifecore” or the “Company”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that John Morberg will be stepping down from his position as chief financial officer to pursue other professional opportunities and spend time with his family, effective September 2, 2024. In addition, the Company is pleased to announce that Ry...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.